Stepan Company reported a 45% year-over-year increase in EBITDA for the second quarter, as the specialty and intermediate chemical manufacturer continued to benefit from margin recovery initiatives and volume growth. The company, which operates 19 facilities across 11 countries, also highlighted progress on its two-year cost-reduction program, Project Catalyst, with realized savings of $18 million to $20 million in Q2 against a $25 million quarterly target.
Revenue growth was broad-based, with organic volume up 6% year-over-year. Stepan’s CFO, Ruben Velasquez, noted that approximately 75% of EBITDA now stems from priority segments, including functional and specialty products, despite consumer-facing volumes remaining significant. The company’s surfactants segment, which accounts for about 70% of sales and 60% of EBITDA, saw commodity surfactants contribute 52% of volume but only 20% of EBITDA, underscoring the shift toward higher-margin offerings.
Project Catalyst, launched in 2026, aims to deliver $100 million in total cost savings over two years, with 60% of the target realized this year and the remainder in 2027. The program has contributed to a reduction in Stepan’s net leverage ratio to 2.5x from 3.0x, while working capital cash usage in Q2 stood at $58 million. Capital expenditures remain normalized at $100 million to $110 million annually.
The company’s stock has gained 25% over the past six months and 34% year-to-date, trading at $62.65 with a market capitalization of $1.42 billion. Stepan’s trailing twelve-month EBITDA is $210 million, with an EV/EBITDA multiple of 9.6. The dividend yield stands at 2.5%, with the company having raised its payout for 55 consecutive years.
Velasquez emphasized the early stages of margin recovery, citing Q2’s performance as evidence of progress. The company’s rigid and spray foam insulation business, a market leader in polyiso panels, saw triple-digit growth in the quarter, reflecting ongoing demand in the reroofing cycle, which typically occurs every 20 to 25 years. Stepan’s Houston lab, staffed by nine scientists, continues to focus on oil and gas applications, aligning with industry trends amid oil prices fluctuating between $80 and $100 per barrel.
Stepan’s global footprint includes a 90-year history in specialty chemicals, with 230 scientists across 14 application centers. The company’s Pasadena, Texas plant is expected to reach an average utilization rate of 80% by year-end, while an organizational redesign has reduced staff by 100 roles. Analysts at the Midwest IDEAS Conference also noted customer pull-forward activity in material securing, contributing an estimated $5 million to $10 million in EBITDA impact for the quarter.
